D000893Chemicals & DrugsD27.505.954.158571000.915386Anti-Inflammatory AgentsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30535188Dub? MP, Chan ES, Lake JE, Williams B, Kinslow J, Landay A, Coombs RW, Floris-Moore M, Ribaudo HJ, Yarasheski KEClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaA Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clin Infect Dis. 2019 09 13; 69(7):1165-1172.Clin Infect Dis2019-09-13T00:00:002019A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.31265894Kedong H, Wang D, Sagaram M, An HS, Chee AThe spine journal : official journal of the North American Spine SocietyAnti-inflammatory effects of interleukin-4 on intervertebral disc cells. Spine J. 2020 01; 20(1):60-68.Spine J2019-06-29T00:00:002019Anti-inflammatory effects of interleukin-4 on intervertebral disc cells.KalipadaPahanKalipada Pahan349039Pahan, KalipadaProfessor99true1ProfessorProfessorAnesthesiologyOtolaryngologyRush University, College of Health SciencesPeteBatraPete Batra349172Batra, PeteProfessorAnaCheeAna Chee349210Chee, Anatrue1ProfessorProfessorCommunication Disorders and SciencesTheodorePincusTheodore Pincus349493Pincus, TheodoreProfessorAsokumarBuvanendranAsokumar Buvanendran349536Buvanendran, AsokumarProfessor4Professor32415419Pahan P, Pahan KJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune PharmacologySmooth or Risky Revisit of an Old Malaria Drug for COVID-19? J Neuroimmune Pharmacol. 2020 06; 15(2):174-180.J Neuroimmune Pharmacol2020-05-15T00:00:002020Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?32658258Ehinger E, Ghosheh Y, Pramod AB, Lin J, Hanna DB, Mueller K, Durant CP, Baas L, Qi Q, Wang T, Buscher K, Anastos K, Lazar JM, Mack WJ, Tien PC, Cohen MH, Ofotokun I, Gange S, Heath SL, Hodis HN, Tracy RP, Landay AL, Kaplan RC, Ley KCardiovascular researchClassical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV. Cardiovasc Res. 2021 03 21; 117(4):1166-1177.Cardiovasc Res2021-03-21T00:00:002021Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV.1.705810.0086615357research area of0.8434740.036342487subject area forNeurological SciencesRush University, Rush Medical College34645689Paidi RK, Jana M, Mishra RK, Dutta D, Pahan KJournal of immunology (Baltimore, Md. : 1950)Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. J Immunol. 2021 11 15; 207(10):2521-2533.J Immunol2021-10-13T00:00:002021Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.true1ProfessorProfessortrue1true1ProfessorProfessorInternal Medicine, Division of Rheumatology